Hormonal treatment for bleeding irregularities in Norplant implant users

Area of Science:

• Reproductive Health
• Contraception
• Endocrinology

Background:

• Norplant (levonorgestrel implant) is a long-acting reversible contraceptive.
• Prolonged or irregular bleeding is a common side effect of Norplant use.
• Effective management strategies for bleeding irregularities are needed.

Purpose of the Study:

• To evaluate the efficacy of oral hormonal medication in alleviating prolonged or irregular bleeding in Norplant users.
• To compare the effectiveness of ethinyl estradiol alone versus a combined oral contraceptive pill.

Main Methods:

• Prospective, randomized, comparative study involving 150 Norplant users experiencing bleeding issues.
• Three treatment groups: ethinyl estradiol (50 mcg), combined oral contraceptive (50 mcg ethinyl estradiol/250 mcg levonorgestrel), and placebo.
• Analysis of total bleeding days during treatment and bleeding-free interval.

Main Results:

• The combined oral contraceptive group experienced significantly fewer bleeding days (2.6 days) compared to ethinyl estradiol (5.4 days) and placebo (12.3 days).
• Both hormonal treatments were significantly more effective than placebo (p <0.00001).
• The combined pill demonstrated superior efficacy over ethinyl estradiol alone (p <0.0001).

Conclusions:

• The combined oral contraceptive pill is an effective palliative treatment for prolonged or irregular bleeding associated with Norplant.
• The combined pill offers a practical and readily available solution for managing this common side effect.